Find Academic Supervisors

Tony RussellView profile

Associate Professor

• RNA Biology
• Evolutionary Biology
• Molecular Genetics
• +5 more

Tony Russell is an Associate Professor in the Department of Biological Sciences at the University of Lethbridge. He earned his PhD in Biochemistry and Molecular Biology from the University of British Columbia and completed postdoctoral research at Dalhousie University, focusing on small RNA structure and evolution in unicellular eukaryotes. Education: PhD, University of British Columbia (Biochemistry and Molecular Biology) Postdoctoral Fellow, Dalhousie University The Russell lab investigates RNA biology and evolution through studies of small RNAs and protein-RNA complexes in protists. Key research areas include spliceosome evolution, intron dynamics, and genomic strategies to identify non-coding RNAs. Organisms under study include Euglena gracilis , Giardia lamblia , and Phytophthora species, with implications for understanding human diseases and pathogen biology. His publications in journals like Nature and RNA highlight discoveries such as ancient spliceosomal introns and novel snoRNA structures. The lab employs biochemical, structural, and bioinformatic approaches to unravel RNA functions and their evolutionary trajectories. Current research involves sequencing protist genomes to annotate small RNA genes and developing methods for identifying RNA modifications. The lab's work contributes to foundational knowledge in eukaryotic biology and potential applications in combating parasitic pathogens.

• Gut Microbiota
• Intestinal Flora
• Fermented Foods
• +5 more

Hans Heilig is a Researcher at Wageningen University & Research , focusing on microbial evolution and its implications in diverse biological systems. His work bridges microbiology, nutrition, and environmental science. Research Interests: His studies center on the gut microbiota in human and animal models, particularly in rural populations and aquaculture. Key areas include the effects of fermented foods on intestinal flora, microbial links to metabolic disorders like obesity and diabetes, and the impact of rearing environments on microbial development in fish (tilapia) and pigs. Collaborations and Projects: Heilig co-investigated the MICRObial processing to reduce and CONTROL emissions (MICROCONTROL) project (2013–2016), contributing to microbial ecology research. He collaborates with leading scientists such as Willem M. de Vos and Hauke Smidt. Research Output: With over 40 peer-reviewed publications, his work appears in journals like Nature Communications , PLoS ONE , and Scientific Reports . His datasets, including 16S ribosomal RNA gene sequences , are publicly accessible.

• Tumor Progression
• Metastasis
• Molecular Imaging
• +7 more

Dr. Wiltrud Lederle serves as a research group leader at the Institute for Experimental Molecular Imaging within the Medical Faculty of RWTH Aachen University. She earned her PhD from the University of Hohenheim following doctoral work at the German Cancer Research Center (DKFZ) in Heidelberg, and conducted postdoctoral research at DKFZ from 2003 to 2008 before joining RWTH Aachen University in 2008. She completed her habilitation at the Medical Faculty of RWTH Aachen University in 2019, establishing her qualification for a professorship in the German academic system. Dr. Lederle's research program centers on understanding tumor-microenvironment interactions through advanced imaging techniques. Her laboratory investigates: The influence of the microenvironment on tumor progression and metastasis Mechanisms of tumor angiogenesis and immune responses Stromal activation during tumor development Non-invasive imaging of stromal remodeling in tissue repair and organ inflammation Development of innovative imaging technologies for cancer research She employs multiple imaging modalities including molecular ultrasound, photoacoustic imaging, MRI, and optical techniques to visualize biological processes in real-time. Her work spans multiple disease areas including colorectal cancer, breast cancer, and various liver conditions, with particular emphasis on angiogenesis, immune responses, and stromal interactions. A significant trend in her recent publications involves developing and validating novel imaging biomarkers for monitoring therapeutic responses and investigating combination therapies targeting both tumor cells and their supportive microenvironment. Dr. Lederle leads the research group 'Tumor Progression and Metastasis' at RWTH Aachen University with continuous funding from major German research agencies including the German Research Foundation (DFG) and the Federal Ministry of Education and Research (BMBF), as well as through industrial partnerships. Her collaborative research program demonstrates strong translational potential, bridging basic science with clinical applications in cancer diagnosis and treatment monitoring.

• Wildlife Forensic Science
• Computational Genomics
• Species Conservation
• +4 more

James Creecy is an Associate Professor and Assistant Director at the W. Roger Webb Forensic Science Institute (FSI) at the University of Central Oklahoma. He co-founded and co-directs the UCO Center for Wildlife Forensic Science and Conservation Studies (C-FACS). Ph.D. in Microbiology, University of Oklahoma M.S. in Biology, New Mexico Institute of Mining and Technology B.S. in Biology, New Mexico Institute of Mining and Technology Creecy’s research focuses on applying advanced genomic technologies and high-performance computational analysis to wildlife forensic investigations. His work centers on improving DNA evidence analysis from wildlife cases using high-throughput sequencing and bioinformatic pipelines like ROWIN (Rapid Online Wildlife Identification Network). He addresses challenges in species conservation, animal protection, and emerging zoonotic diseases. His peer-reviewed publications and presentations highlight trends in wildlife forensic science, including DNA rehabilitation techniques, mitochondrial sequencing, and AI-driven forensic analysis. Recent work explores marine and terrestrial environmental impacts on DNA preservation, forensic nanotechnology, and computational tools for species identification. Researcher of the Year, Sigma Xi Chapter (2017) Sigma Xi Chapter President (2018-19) Delta Delta Epsilon International President (2011-15) Creecy has advised students on diverse projects, including rat lungworm epidemiology, forensic hair extensions, and bloodstain pattern analysis. His collaborations span local, national, and international partners, emphasizing interdisciplinary approaches to wildlife forensics and conservation. He actively contributes to workshops and presentations, including the Society for Wildlife Forensic Science and American Academy of Forensic Sciences meetings.

• Neuroscience
• Neurosurgery
• Traumatic Brain Injury
• +4 more

Mattias Sköld serves as an Adjunct Lecturer at Karolinska Institutet's Department of Neuroscience and Associate Professor of Neurosurgery at Uppsala University, concurrently functioning as Senior Consultant Neurosurgeon at Akademiska Sjukhuset Uppsala and Senior Researcher in Neuroscience. His academic credentials include: M.D. from Karolinska Institutet (2003) Ph.D. in Neuroscience from Karolinska Institutet (2004) Medical Internship at Karolinska University Hospital (2004-2006) Neurosurgery residency at Akademiska Sjukhuset Uppsala (2006, 2012-2019) Sköld's research investigates traumatic nervous system injuries through methodologies ranging from in vitro cavitation models to animal studies, with military medicine applications forming a critical focus. His work examines blast-induced trauma mechanisms, neural regeneration pathways, and molecular responses to high-energy injuries, particularly emphasizing VEGF signaling and inflammatory cascades in neural repair processes. Analysis of his 15 most recent publications reveals consistent exploration of blast injury modeling frameworks, peripheral nerve regeneration techniques using biomaterials, and temporal gene expression patterns following neural trauma across military and civilian contexts. No scientific awards are documented in the provided materials. He supervises Ph.D. students in both basic neuroscience and clinical neurosurgery domains. Current research is supported by Swedish Research Council grants including "Novel strategies for nervous tissue regeneration" (2020-2023) and previously "Targeted anti-inflammatory treatment in traumatic brain injuries" (2009-2010). Sköld leads Karolinska Institutet's Experimental Traumatology Research Unit and contributes to multiple NATO human factors and medicine task groups focused on brain injury modeling standards and combat casualty care performance metrics.

Geoffrey WasteneysView profile

Professor

• Plant Cell Biology
• Microtubule Dynamics
• Cellulose Biosynthesis
• +6 more

Geoffrey Wasteneys is a Professor in the Department of Botany at the University of British Columbia's Faculty of Science. He holds a Canada Research Chair Tier 1 in Plant Cell Biology and leads an active research laboratory focused on plant cell biology and development. His work bridges molecular biology, cell biology, and plant physiology to understand fundamental mechanisms of plant growth. Dr. Wasteneys received his B.Sc. in Biology from Carleton University in 1983 and his Ph.D. in Plant Cell Biology from the Australian National University in 1989. His early career included prestigious fellowships including the National Research Fellow (1988-91), Humboldt Fellow (1992-1993) at the University of Heidelberg, Queen Elizabeth II Fellow (1992-1998), and Fellow/Senior Fellow positions (1996-2004) at the Australian National University. Dr. Wasteneys' research primarily focuses on plant cell biology with emphasis on microtubule dynamics, cellulose biosynthesis, and plant cell wall formation . His laboratory investigates how microtubule arrays organize to guide cellulose deposition and influence plant cell shape and tissue mechanics. His work has significant implications for understanding plant growth, development, and responses to environmental stresses. Analysis of Dr. Wasteneys' recent publications reveals a consistent focus on microtubule-associated proteins (particularly CLASP), cellulose synthase complexes, and their roles in plant cell morphogenesis . His research spans from molecular mechanisms of protein function to whole-plant developmental processes, with particular attention to root development, cell wall biosynthesis, and plant responses to environmental cues. A notable trend in his recent work is the integration of advanced imaging techniques with genetic and molecular approaches to study dynamic cellular processes. Canada Research Chair Tier 1 in Plant Cell Biology National Research Fellow (1988-91) Australian National University Humboldt Fellow (1992-1993) University of Heidelberg Queen Elizabeth II Fellow (1992-1998) Australian National University Fellow/Senior Fellow (1996-2004) Australian National University Dr. Wasteneys actively mentors the next generation of plant scientists, currently supervising multiple PhD and MSc students in his laboratory. His research is supported by competitive grants including the Canada Research Chairs program. His laboratory provides training in advanced cell biological techniques, molecular genetics, and plant physiology, preparing students for diverse careers in academia and industry. The Wasteneys Lab at UBC serves as a hub for plant cell biology research, bringing together students and researchers to investigate fundamental questions about plant cell organization and function. The lab utilizes cutting-edge microscopy, molecular genetics, and biochemical approaches to unravel the mechanisms that drive plant development.

• Molecular Biology
• Genetics
• Neuroscience
• +3 more

Dr. Jeffrey Y. Lee is a Researcher at the University of Glasgow , affiliated with the Institute of Molecular Cell and Systems Biology within the College of Medical, Veterinary and Life Sciences. His work focuses on RNA regulation in developmental biology and neuroscience. Institution: University of Glasgow Department: Institute of Molecular Cell and Systems Biology Email: Jeff.Lee@glasgow.ac.uk Research Interests: Dr. Lee investigates RNA-binding proteins (e.g., Imp/IGF2BP and Syp/SYNCRIP) in Drosophila brain development, glial mRNA localization in plasticity, and viral mechanisms in HIV-1 infection. His work bridges molecular biology, genetics, and neurodevelopmental biology. Publication Trends: Recent articles highlight his expertise in RNA interactomes (2025), advanced imaging techniques (2024), and cross-species transcriptomic analysis (2024). Studies span developmental processes, neural plasticity, and virology, with a focus on Drosophila models and HIV-1 dynamics. Advising & Collaborations: While formal student lists are absent, he collaborates with researchers like Dr. Ilan Davis, Maria Kiourlappou, and Rita O. Teodoro on interdisciplinary projects in molecular biosciences.

• Genomics
• Epigenetics
• Systems Biology
• +7 more

Gary Hon is an Assistant Professor at the University of Texas Southwestern Medical Center (UTSW), jointly affiliated with the Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Lyda Hill Department of Bioinformatics. His research lies at the intersection of genomics, epigenetics, and systems biology, with a focus on decoding the regulatory complexity of the human genome. His research interests include: Understanding the molecular basis of cell state for applications in regenerative medicine Elucidating how non-coding genetic variants contribute to development and disease Developing integrative techniques combining gene regulation, epigenetics, genome engineering, and single-cell genomics Advancing bioinformatics tools for analyzing chromatin and transcriptional regulation The trends across his recent publications reveal a strong emphasis on enhancer biology, epigenetic modifications (especially 5mC and 5hmC), single-cell functional genomics, and the development of novel molecular tools such as in situ chromatin capture and combinatorial perturbation assays. His work frequently leverages CRISPR-based technologies and high-throughput sequencing to dissect gene regulatory networks. Dr. Hon has received significant recognition for his innovative research, including: CPRIT Scholar NIH Director’s New Innovator Award Dr. Hon leads the Hon Lab, which actively develops and applies systems-level approaches to study genome regulation. His collaborative research involves advising graduate students and postdoctoral fellows, many of whom appear as co-authors on his publications. While specific grant details are not listed, his prestigious awards suggest substantial federal and state funding support for his high-impact, interdisciplinary research program.

Alireza AhadiView profile

Part-Time Lecturer

• Data Science
• Machine Learning
• Educational Data Mining
• +9 more

Dr Alireza Ahadi is a PartTime Lecturer at the Faculty of Engineering & Information Technology , University of Technology Sydney. He holds a PhD in Data Analytics from UTS (2018) and has previously worked as a postdoctoral researcher at Macquarie University (2019-2022) focusing on skills analytics and educational data mining. Education: PhD in Data Analytics (UTS, 2018), Master of Information Technology Extended (UTS, 2013), Bachelor in Computer Science (UTS, 2010). Current Role: Teaching IT and Science subjects at UTS with expertise in databases, programming languages, and data science. Research Interests center on data-driven educational solutions , including text mining in education, skills gap analysis between academia and job markets, code comprehension studies, and miRNA regulation in cancer research. His work integrates machine learning with curriculum analytics to improve educational outcomes and workforce alignment. Recent publications (15 most) reveal trends in applying NLP to educational data, eye-tracking analysis for programming behavior, and skills analytics engines for curriculum-job market mapping. His 2022 article on skills gap identification using Burning Glass data highlights his focus on real-world educational impact. Teaching Experience includes coordination and lecturing in core subjects like Database Fundamentals, Programming Languages, and Data Structures at UTS. He also explores educational data mining , optimization of analytics engines , and recommendation system design in pedagogical contexts.

Tarik MöröyView profile

Research Professor

• Molecular Biology
• Immunology
• Hematology
• +7 more

Dr. Tarik Möröy is a Full Research Professor at the Faculty of Medicine of the Université de Montréal and serves as the President and Scientific Director of the Montreal Clinical Research Institute (IRCM). He is a leading expert in molecular biology, immunology, and cancer research, with over 180 publications, an h-index of 66, and 13,500+ citations. His work focuses on the transcriptional and epigenetic regulation of hematopoiesis and its role in immune system malignancies. Education Ph.D. in Biochemistry, University of Ludwig-Maximilians, Munich (1987) Postdoctoral Researcher, Columbia University, New York (1988–1991) Research Interests Dr. Möröy investigates the molecular mechanisms of immune cell differentiation and leukemogenesis, emphasizing transcription factors (GFI1, GFI1B, c-Myc, Miz-1), RNA helicases (DDX3X), and long non-coding RNAs (lncRNA). His lab combines multiplex flow cytometry, genomics, and computational biology to model hematopoietic malignancies. Publication Trends Recent work explores GFI1/PRMT1 interactions in DNA repair, DDX3X in lymphoid differentiation, and lncRNAs in leukemia. Themes include transcriptional regulation, epigenetic mechanisms, and RNA biology in hematopoietic cancers. Scientific Awards Canada Research Chair (Tier 1) in Hematopoiesis and Immune Cell Differentiation (2007–2021) IRC Medal of Merit for Exceptional Service (2019) Elected member of the Canadian Academy of Health Sciences (2018) Advising and Leadership Dr. Möröy has mentored doctoral students like Marion Lacroix and leads a multidisciplinary team at the IRCM. He has served on national and international scientific advisory boards, including Recherche Canada (President since 2023) and the Canadian Society for Molecular Biosciences (President 2018–2020).

Alice TelesnitskyView profile

Professor

• Retrovirology
• RNA Biology
• HIV-1 Research
• +3 more

Alice Telesnitsky is a Professor at the Department of Microbiology and Immunology, University of Michigan Medical School. Her research focuses on HIV-1 RNA biology, including transcription start site heterogeneity, genome packaging, and epigenetic mechanisms of viral persistence. BS in Genetics, University of California, Davis (1979) PhD in Biochemistry, University of California, Berkeley (1988) Postdoctoral fellowship at Columbia University Her work reveals how HIV-1 employs diverse RNA isoforms with distinct functions in replication and pathogenesis. Recent studies highlight RNA structural plasticity, cap-sequestration mechanisms, and transcriptional start site dynamics in viral RNA fate. Collaborated on 20+ publications on HIV-1 replication and RNA structure Led research on transcription start site heterogeneity and its role in viral evolution Co-authored studies on APOBEC3H antiviral activity and UBQLN2 protein toxicity As an MCIDT Affiliate, she investigates HIV-1 genome packaging with collaborators like Michael Summers and James Munro, contributing to understanding HIV therapeutics targets via RNA structural analysis.

Trung Nghia VuView profile

Researcher

• Bioinformatics
• Computational Biology
• Cancer Genomics
• +5 more

Trung Nghia Vu is a Principal Researcher at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden. His research group focuses on developing and applying statistical and bioinformatics methods for molecular biology and medicine, with particular emphasis on cancer genomics and pharmacogenomics. Dr. Vu received his PhD from the Department of Mathematics and Computer Science at the University of Antwerp, Belgium (2009-2014), following an MSc in Computer Engineering from Korea Aerospace University (2006-2008) and a BSc in Technology from Vietnam National University in Hanoi (2000-2004). His research focuses on developing statistical and bioinformatics methodologies for analyzing high-throughput omics data, with specific interests in single-cell sequencing analysis, characterization of cancer omics, and pharmacogenomics. His group has developed 20 statistical and bioinformatics tools available through Biostat Wiki Primary research areas include gene/isoform quantification, detection of abnormal RNAs, single-cell RNA-seq analysis, and drug response prediction Current projects focus on breast cancer and Acute Myeloid Leukemia (AML) Analysis of Dr. Vu's recent publications reveals a strong focus on cancer genomics, particularly in AML and breast cancer. His work bridges computational biology with clinical applications, developing methods for spatial transcriptomics, drug synergy prediction, and circular RNA analysis. The research demonstrates a clear trajectory toward precision medicine applications, with increasing emphasis on personalized drug response prediction and pathway activation modeling. Dr. Vu actively supervises multiple students and researchers, including both completed PhD students (Quang Thinh Trac, Lu Pan, Wenjiang Deng) and ongoing supervisees (Gulser Caliskan, Meghana Alugunoolla, Yuying Li, Aron Arzoomand). His research is supported by significant grants from the Swedish Research Council, CancerFonden, and Karolinska Institutet. He leads the Computational Medicine and Bioinformatics research group at Karolinska Institutet, which collaborates with international clinical and systems-biology researchers. The group maintains active development of bioinformatics tools and maintains the Biostat Wiki platform for academic use. Dr. Vu also contributes to teaching through master's and doctoral courses in biostatistics and R programming at Karolinska Institutet.

• Food Science
• Microbiology
• Biochemistry
• +3 more

Maria Leticia Miranda Fernandes is a Researcher at the Polytechnic Institute of Bragança , with a focus on food science, microbiology, and biochemical characterization of beekeeping by-products. Her work spans 30 years and includes 283 publications , with extensive collaborations across Brazil and Portugal. Research Interests Food safety and microbiology Antioxidant and antimicrobial mechanisms Chemical profiling of natural products High-pressure food processing Stingless bee product applications Pharmacological evaluation of plant extracts Scientific Awards Highly Cited Researcher (Cross-Field) - Web of Science (2018-2023) Stanford University Top 2% Scientists (2020-2023) Multiple 'Prémio Inventor' awards from CINOVA/UFRB (2015, 2019) Best Poster Awards (2010, 2013) Her research has been supported by grants from Fundação para a Ciência e Tecnologia (FCT) and institutional partnerships with Brazilian universities. She leads studies on mead production, propolis applications, and foodborne pathogen control.

Domenico PraticòView profile

Professor

• Clinical Pharmacology
• Oxidative Biology
• Alzheimer's Disease
• +4 more

Domenico Praticò, MD, FCPP is a Professor in the Department of Neural Sciences at Lewis Katz School of Medicine, Temple University, and the Founding Director of the Alzheimer's Center at Temple. His research focuses on clinical pharmacology, oxidative biology, and neurodegeneration. MD, University of Rome "La Sapienza" (1986) Internship, Residency, and Fellowship at University of Rome "La Sapienza" Cardiovascular Science Fellowship, University of Dublin (1994) Dr. Praticò investigates the role of bioactive oxidized lipids, oxidative stress, and neuroinflammation in aging, Alzheimer's disease, and cardiovascular disorders. His lab employs cellular and animal models to translate findings into human disease understanding. Recent publications highlight his work on Alzheimer's disease mechanisms involving non-coding RNAs, endosomal trafficking, lipid metabolism, autophagy, and vascular contributions. His studies bridge neurobiology, cardiovascular research, and translational medicine. Fellow of the Center for Clinical Pharmacology (FCPP) His lab integrates in vitro systems and transgenic mouse models to study APP processing, Aβ metabolism, tau pathology, and synaptic dysfunction. The Pratico Lab emphasizes drug discovery for neurotherapeutics and biomarker identification.

Darrell R. DavisView profile

Professor

• RNA Biology
• Antiviral Therapeutics
• Virology
• +3 more

Darrell R. Davis serves as Professor of Medicinal Chemistry and Adjunct Professor of Biochemistry at the University of Utah, with primary affiliation in the Department of Medicinal Chemistry and active roles in the Molecular Biology and Biological Chemistry Programs. His educational credentials include a B.S. from the University of Puget Sound and a Ph.D. from the University of Utah, establishing deep institutional roots. Research focuses on RNA structure-function relationships in viral pathogenesis, specifically developing host-targeted antivirals that disrupt viral mRNA translation mechanisms across diverse pathogens including SARS-CoV-2, HCV, and Zika virus. Laboratory work has identified enantiomerically specific compounds like DD011-E2 (EC 50 = 140 nM against SARS-CoV-2) with conserved activity against phylogenetically distant viruses, indicating a novel mechanism targeting cellular processes. Publication analysis reveals consistent emphasis on RNA structural biology applied to antiviral discovery, spanning fundamental tRNA/HIV-1 interactions to translational control elements in HCV IRES. Methodologies integrate molecular dynamics simulations, NMR spectroscopy, and cell-based antiviral assays across all studies, demonstrating interdisciplinary rigor in targeting RNA for therapeutic intervention. No scientific awards are documented in the source material. Dr. Davis leads an active research laboratory (accessible via Lab Page link) with extensive collaborative networks evident in co-authorship patterns, though specific grant details remain unreported. He mentors graduate students in medicinal chemistry and virology, contributing to both the Biological Chemistry and Molecular Biology Ph.D. programs through curriculum development and research supervision. Laboratory infrastructure supports RNA structural analysis and antiviral screening, with current work optimizing lead compounds against pandemic-capable viruses through mechanistic elucidation of host-targeted inhibition pathways.